Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI). Its collaboration with ...

As Global Head of Oncology for IQVIA Biotech, Gerhard du Toit manages all aspects of oncology clinical trials, optimising strategies and enhancing delivery from early to late phases. With more ...

NHS England has started a pilot trial of an iPhone app and device combination that could be used by nursing staff to speed up reviews of suspected throat cancer. The technology consists of an ...

AstraZeneca plans to invest a whopping $3.5 billion to expand its R&D and manufacturing operations in the US by 2026, as part of a drive to raise its revenues to $80 billion by the end of the decade.

Robert F. Kennedy, Jr. speaking with attendees at the 2024 FreedomFest at Caesars Forum Conference Center in Las Vegas, Nevada. Image of Robert F Kennedy Jr by Gage Skidmore, sourced from Flickr.

Artificial intelligence (AI) is transforming the pharmaceutical industry, revolutionising drug discovery and approval processes, and reshaping how researchers identify potential drug candidates ...

A new report says that London is the top city in Europe for the life sciences industry, and ranks third worldwide after Boston and New York in the US. That puts the city above some well-recognised ...

Shares in AbbVie have slumped after a pair of failed phase 2 trials for emraclidine, a schizophrenia drug it acquired as part of its $8.7 billion takeover of Cerevel Therapeutics last year.

Investors in the cell therapy industry are actively looking into solid tumours, autoimmune indications and novel engineering as the best place to allocate their money and resources. This, along ...

Adcendo has tapped into the strong investor appetite for companies developing antibody-drug conjugates for cancer with an ...

Today, 36 million people in the European Union (EU) and 30 million in the US with a rare disease face the harsh reality of a ...

Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid ...